Dermatologicals in France - New Report Available

From: Fast Market Research, Inc.
Published: Fri Jul 18 2014


Sales of dermatologicals continued to be impacted by rather favourable factors in 2013, such as a growingly wide offering (for instance, in antiparasitics/lice (head and body) treatments), the consequences of switch of Minoxidil 5% to strict OTC in hair loss treatments in 2012, fewer scruples and taboos in haemorrhoid treatments or the impact of weather and outdoor activities on sales of topical germicidals/antiseptics. In addition, the confidence and willingness of French consumers to independently self-medicate with dermatologicals still increases in an ongoing gloomy economic context due to the EU debt crisis. Coupled with heavy advertising investment by the key players, this contributes to keeping this consumer health category afloat.

Competitive Landscape

With a 16% value share in 2013, Johnson & Johnson Sante Beaute France was the outright leader in dermatologicals. Its nearest contender, Laboratoires Pierre Fabre, ranks far behind with a 10% value share in 2013. This leadership relies on its wide portfolio that includes powerful brands, such as Neutrogena T/Gel in medicated shampoos, Daktarin and Pevaryl in topical antifungals, Gyno-Pevaryl in vaginal antifungals, Alostil in hair loss treatments, Compeed in cold sore treatments, Biafine in topical germicidals/antiseptics and mainly Titanoreine, which scored a hit in recent years in haemorrhoid treatments, according to trade press.

Full Report Details at
- http://www.fastmr.com/prod/836613_dermatologicals_in_france.aspx?afid=303

Industry Prospects

Marketers are not too pessimistic about the outlook in dermatologicals. French consumers want to take greater care of their bodies, and, due to continuous information campaigns, an increasing number of potential consumers will become aware of issues related to the skin. In addition, manufacturers know how to overcome the tricky situation of the category that is squeezed between reimbursed Rx products, dermocosmetic products in pharmacies and growingly audacious cosmetic brands in grocery retailers. Dermocosmetics are cosmetic products with a para-pharmacy positioning and available in pharmacies - not included in the consumer healthcare market. Hydralin, Biafine, Biseptine and many other brands show it is possible to keep the loyalty of consumers who prefer the caution of OTC-prescribed products and recruit new ones with pure OTC such as Biseptinespraid or even dermocosmetic new brand variants, like SensiBiafine.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in France with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Dermatologicals in the US
- Dermatologicals in Thailand
- Dermatologicals in Israel
- Dermatologicals in Ireland
- Dermatologicals in Japan
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »